Necessary, but not sufficient reading for building genomic survival prediction models on TCGA https://t.co/L0dPYEVsmi
Not exactly what was requested, but the discussion in TCGA Pancan Atlas may be helpful: https://t.co/ix1MvjomIr
@sexchrlab @GreeneScientist @delfuego @JCZenklusen If im remembering correctly, this is the relevant resource (one sup table has info for all patients) https://t.co/TdqHKPbrWW
RT @NCIDataSci: The #TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR) is a standardized dataset created as a result of the Cancer Genome A…
RT @NCIDataSci: The #TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR) is a standardized dataset created as a result of the Cancer Genome A…
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. https://t.co/JX5yfmFJab
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics https://t.co/6wenZ5Ukae
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
If you use the #TCGA data this paper would be useful for survival analysis. "An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics" https://t.co/R77RdB8WB4
The #TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR) is a standardized dataset created as a result of the Cancer Genome Atlas project, which collected data on more than 11,000 human tumors across 33 different cancer types. Read this paper to learn more.
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @MattoGrosso: It has been almost 20 years I curate clinical data for my own projects. It was about time, thanks! https://t.co/L568ik77iv
RT @difersanchez: Finally!!! There is a lot of preprocessing steps in order to get enough reliable clinical information from TCGA. https://…
Finally!!! There is a lot of preprocessing steps in order to get enough reliable clinical information from TCGA. https://t.co/gCMjZ6SQbj
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
It has been almost 20 years I curate clinical data for my own projects. It was about time, thanks! https://t.co/L568ik77iv
RT @FertigLab: Important considerations and all the more complex when considering linking to genomics for biomarkers. https://t.co/mpgdxF7n…
Important considerations and all the more complex when considering linking to genomics for biomarkers. https://t.co/mpgdxF7ne2
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
RT @NCIgenomics: #TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analy…
#TCGA #PanCancer Clinical Data Resource details challenges and statistical limitations of integrating clinical data, analysis of clinical outcome endpoints with usage recommendations https://t.co/pFmcGqhifQ https://t.co/BddggiMQG8
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
one of the most comprehensive study. https://t.co/PDZOLFOe2Y
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
Finally there is curated survival dataset for TCGA! https://t.co/Sk2gR0tiDc
Really useful genomics *plus clinical outcome* #PanCancer dataset! #TCGA @NCIgenomics #cancerresearch Let’s get to work https://t.co/xQ4i9sci7b
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
RT @NCIgenomics: #PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease…
#PanCancer clinical data resource for 11,000 #TCGA patients includes clinical outcome endpoints: overall survival, disease-specific survival, disease-free interval, progression-free interval and usage recommendations https://t.co/pFmcGqhifQ https://t.co/GZ
RT @UCSCXena: We've loaded the TCGA PanCan Atlas curated survival data (https://t.co/x9FKKteNzo) to allow you to choose between multiple su…
RT @UCSCXena: We've loaded the TCGA PanCan Atlas curated survival data (https://t.co/x9FKKteNzo) to allow you to choose between multiple su…
The updates wheel is up! #pancancer #TCGA @UCSCXena . Great job! https://t.co/c9ocACMmhf
We've loaded the TCGA PanCan Atlas curated survival data (https://t.co/x9FKKteNzo) to allow you to choose between multiple survival end points. https://t.co/0JyPppamVp https://t.co/idlFCXrkSf
RT @andbeonetravelr: Survival and progression endpoints for #TCGA patients with usage recommendations. Pretty stoked to start using this da…
RT @andbeonetravelr: Survival and progression endpoints for #TCGA patients with usage recommendations. Pretty stoked to start using this da…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
Survival and progression endpoints for #TCGA patients with usage recommendations. Pretty stoked to start using this data https://t.co/2K6ltZShhT
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…
RT @CellCellPress: Analysis of clinicopathologic annotations for >11,000 #cancer patients in the #TCGA leads to the TCGA Clinical Data Reso…